Registry for Upper Gastrointestinal Bleeding

The Orange County Bleeding Consortium (OCBC): Registry of Patients Undergoing Endoscopic Procedures for Upper Gastrointestinal Bleeding in AdventHealth Hospitals in Central Florida

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04211194

Enrollment

2999

Registered

2019-12-26

Start date

2019-10-01

Completion date

2021-01-31

Last updated

2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic Ulcer, Acute With Hemorrhage, Peptic Ulcer Hemorrhage

Brief summary

This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.

Detailed description

This project is being performed to evaluate the outcomes of patients undergoing endoscopic procedures for upper gastrointestinal bleeding at all AdventHealth hospitals in Central Florida. This information will enable quality control of patients undergoing treatment for upper gastrointestinal bleeding across all campuses in the AdventHealth system in Central Florida and hence improve the delivery ot care extended to the investigator's patients.

Interventions

PROCEDUREUpper GI Endoscopy

Patients with upper gastrointestinal bleeding undergoing endoscopic therapy. Information regarding the need for interventional radiology procedures or surgical interventions will also be collected in patients in whom endoscopic therapy is not successful.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient is 18 years of age or greater * Patient is undergoing endoscopic treatment for upper gastrointestinal bleeding

Exclusion criteria

* Under the age of 18 * Patient not undergoing endoscopic treatment for upper gastrointestinal bleeding

Design outcomes

Primary

Measure	Time frame	Description
Mortality Rate	30 days	Mortality rate from upper gastrointestinal bleeding and from any etiology

Secondary

Measure	Time frame	Description
Rate of Recurrence	30 days	Recurrence of upper gastrointestinal bleeding following endoscopic treatment
Rate of Readmission	30 days	Need for readmission to hospital for treatment of upper gastrointestinal bleeding
Rate of Reintervention	30 days	Need for repeat endoscopic treatment for upper gastrointestinal bleeding
Costs	30 days	Total hospital costs from admission for upper gastrointestinal bleeding
Treatment success	30 days	Successful treatment of upper gastrointestinal bleeding using endoscopic therapy as determined by a yes/no answer.
Length of hospital stay	30 days	Length of hospitalization from index endoscopic procedure to discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026